RecruitingNot ApplicableNCT06687018

Effects of Kaltenborn and Mulligan Mobilisation in Patients With Carpal Tunnel Syndrome.

Comparative Effects of Kaltenborn Versus Mulligan Mobilisation on Pain, Disability and Hand Function in Patients With Carpal Tunnel Syndrome

Sponsor

Riphah International University

Enrollment

48 participants

Start Date

Jan 4, 2024

Study Type

INTERVENTIONAL

Conditions

Carpal Tunnel Syndrome (CTS)

Summary

Carpal Tunnel Syndrome is the most common mononeuropathy that results from the compression of median nerve in carpal tunnel, leading to entrapment neuropathy. The symptoms become aggravated during drawing, typing or playing video games. The aim of study will be to compare the effects of Kaltenborn and Mulligan mobilisation on pain, disability and hand function in patients with carpal tunnel syndrome.

Eligibility

Min Age: 20 YearsMax Age: 45 Years

Inclusion Criteria3

Both genders between 20 and 45 years of age
Individuals having localized pain, tingling and numbness in the median nerve distribution
Positive Tinel sign and positive Phalen's test

Exclusion Criteria3

Any sensory and/or motor deficit in either the ulnar or radial nerve traumatic neck injury
Previous hand surgery or trauma or cervical radiculopathy
Systemic disease e.g. diabetes mellitus or thyroid disease or rheumatoid arthritis

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERKaltenborn mobilisation

Kaltenborn mobilisation Grade 3 along with common treatment for 3 minutes, repeated 3 sets with rest of 1 minutes, three sessions per week for four weeks. Conventional treatment comprises a hot pack for 10 minutes, SWD for 5 minutes, and nerve and tendon gliding exercises.

OTHERMulligan mobilisation

Mulligan mobilisation with 10 repetitions with 3 sets and three sessions per week for four weeks. Conventional treatment comprises a hot pack for 10 minutes, SWD for 5 minutes, and nerve and tendon gliding exercises